KR890014104A - 심장과 심맥관계에 특히 작용하는 약학적 조성과 이의 제조방법 공정 - Google Patents

심장과 심맥관계에 특히 작용하는 약학적 조성과 이의 제조방법 공정 Download PDF

Info

Publication number
KR890014104A
KR890014104A KR1019890003678A KR890003678A KR890014104A KR 890014104 A KR890014104 A KR 890014104A KR 1019890003678 A KR1019890003678 A KR 1019890003678A KR 890003678 A KR890003678 A KR 890003678A KR 890014104 A KR890014104 A KR 890014104A
Authority
KR
South Korea
Prior art keywords
weight
composition
unsaturated fatty
fatty acids
acid
Prior art date
Application number
KR1019890003678A
Other languages
English (en)
Inventor
리테라티 나기 페테르
라드바니 니 헤게뒤스 에리자베트
보로스 마리아
스칠 베레키 예노
블라스코 게오르규
가챠리이 벨라
하마르 니 네메스 기젤라
네메스 가보르
Original Assignee
원본미기재
비오렉스 케이 에프 티
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 원본미기재, 비오렉스 케이 에프 티 filed Critical 원본미기재
Publication of KR890014104A publication Critical patent/KR890014104A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Pain & Pain Management (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Emergency Medicine (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Obesity (AREA)

Abstract

내용 없음.

Description

심장과 심맥관계에 특히 작용하는 약학적 조성과 이의 제조방법 공정
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (10)

  1. 적어도 2개의 불포화 결하을 갖는 C18-24지방산을 중량대비 99.5-50% 함유할 뿐만 아니라 0.5-50% 중량대비 셀레늄-함유 미생물 및/혹은 유도체와 담체 및/혹은 제약계에서 흔히 사용하는 부형제와 임의의 항산화제로 구성되는 심장과 순환기계에 작용하는 약학적 조성.
  2. 제1항의 조성에서, 구성은 5-25% 중량대비 설레늄 함유 미생물과 95-65% 중량대비 불포화 지방산 혹은 그 유도체.
  3. 제1항의 조성에서, 구성은 15-35% 중량대비 설레늄 함유 미생물과 85-75% 중량대비 불포화지방산.
  4. 제1항의 조성에서, 구성은 불포화 지방산이 바다 생선기름으로부터 추출된 지방산.
  5. 제1항의 조성에서, 구성은 불포화 지방산이 5,8,11,14,17-에이코사펜타에노익산과 4,7,10,13,16,19-도코사헥사에노익산.
  6. 적어도 2개의 불포화 결합을 같는 C18-24지방산을 중량대비 99.5-50% 함유할 뿐만아니라, 0.5-50% 중량대비 셀레늄-함유 미생물 및/혹은 유도체와 담체 및/혹은 제약계에서 흔히사용하는 부형제와 임의의 항산화제를 제약계에서 통상되는 방법을 제조한 심장과 심맥관계에 작용하는 약학적 조성의 제조방법의 과정.
  7. 제6항의 과정에서, 5-35% 중량대비 설레늄-함유 미생물을 95-65% 중량대비 불포화 지방산과 혼합시키는 방법.
  8. 제6항의 과정에서, 15-25% 중량대비 설레늄 함유 미생물을 85-75% 중량대비 불포화 지방산과 혼합시키는 방법.
  9. 제6항의 과정에서, 바다 생선 기름으로부터 추출된 지방산을 불포화 지방산으로 사용하는 방법.
  10. 제6항의 과정에서, 불포화 지방산으로써 5,8,11,14,17- 에이코사펜타에노익산과 4,7,10,13,16,19-도코사헥사에노익산을 사용하는 방법.
    ※ 참고사항:최초출원 내용에 의하여 공개하는 것임.
KR1019890003678A 1988-03-23 1989-03-23 심장과 심맥관계에 특히 작용하는 약학적 조성과 이의 제조방법 공정 KR890014104A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU881484A HU210122B (en) 1988-03-23 1988-03-23 Process for production of composition against thromboembolytic conditions of circulating system and heart
HU2251-1484 1988-03-23

Publications (1)

Publication Number Publication Date
KR890014104A true KR890014104A (ko) 1989-10-21

Family

ID=10954680

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019890003678A KR890014104A (ko) 1988-03-23 1989-03-23 심장과 심맥관계에 특히 작용하는 약학적 조성과 이의 제조방법 공정

Country Status (15)

Country Link
JP (1) JPH0222228A (ko)
KR (1) KR890014104A (ko)
BE (1) BE1003021A3 (ko)
CA (1) CA1319607C (ko)
CH (1) CH677732A5 (ko)
DE (1) DE3909707A1 (ko)
ES (1) ES2014060A6 (ko)
FI (1) FI891438A (ko)
FR (1) FR2628972B1 (ko)
GB (1) GB2216421A (ko)
HU (1) HU210122B (ko)
IT (1) IT1229205B (ko)
LU (1) LU87488A1 (ko)
NL (1) NL8900742A (ko)
SE (1) SE8901041L (ko)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR19990015198A (ko) * 1997-08-02 1999-03-05 손남율 식물성 항생제

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3114198B2 (ja) * 1990-11-06 2000-12-04 ソニー株式会社 電子機器
BE1012495A3 (fr) 1999-03-02 2000-11-07 Messadek Jallal La glycine-betaine pour son usage antithrombotique.
US7608640B2 (en) 1999-03-02 2009-10-27 Jallal Messadek Glycine betaine and its use
GB2363331B (en) * 2000-06-17 2003-02-05 Raymond Clifford Noble Supplement to enhance fertility
FR2816211B1 (fr) * 2000-11-08 2005-04-01 Brif Nouvelles compositions dietetiques et ou/cosmetiques pour ameliorer la secheresse des muqueuses
BE1015608A6 (fr) 2003-07-15 2005-06-07 Messadek Jallal Traitement des arterites.
US8729124B2 (en) 2002-03-05 2014-05-20 Pronova Biopharma Norge As Use of EPA and DHA in secondary prevention
CA2485116C (en) * 2002-05-03 2013-02-05 Pronova Biocare As Use of epa and dha in secondary prevention
US20040076695A1 (en) 2002-07-08 2004-04-22 Advanced Vision Research EPA and DHA enriched omega-3 supplement for the treatment of dry eye, meibomianitis and xerostomia
US20060233863A1 (en) 2003-02-10 2006-10-19 Enzymotec Ltd. Oils enriched with diacylglycerols and phytosterol esters and unit dosage forms thereof for use in therapy
FR2863170A1 (fr) * 2003-12-08 2005-06-10 Nicolai Christian Paul Xavier Composition regeneratrice et regulatrice de l'appareil digestif
RU2380983C2 (ru) * 2004-08-09 2010-02-10 Энзимотек Лтд. Пищевой продукт для диабетиков
EP1796726A2 (en) 2004-08-10 2007-06-20 Enzymotec Ltd. Mixture of phytosterol ester(s) and 1,3-diglyceride(s) for use in the treatment of medical conditions
WO2006050581A2 (en) 2004-11-10 2006-05-18 Jallal Messadek Betaine as agent against arthropod - or mosquito -borne diseases
HU227588B1 (hu) * 2004-12-03 2011-09-28 Sinnex Mueszaki Fejlesztoe Es Tanacsado Kft Többszörösen telítetlen zsírsavak észtereit tartalmazó vírusellenes és immunstimuláns gyógyászati készítmény
WO2006086856A1 (en) 2005-02-15 2006-08-24 Messadek, Jallal Combination therapeutic compositions and method of use
JP2009506978A (ja) 2005-04-27 2009-02-19 メッサデク ジャアル インスリン類の併用
ITMI20052483A1 (it) * 2005-12-23 2007-06-24 Novamont Spa Esche biodegradabili
FR2935394B1 (fr) 2008-08-29 2013-03-08 Eco Solution Microorganismes photosynthetiques enrichis en selenium organique a partir de composes seleno-hydroxyacides et leurs applications en nutrition, cosmetique et pharmacie
FR2935393B1 (fr) 2008-08-29 2012-08-24 Tetrahedron Bacteries et levures enrichies en selenium organique a partir de composes seleno-hydroxyacides et leurs applications en nutrition, cosmetique et pharmacie

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1239587A (en) * 1983-10-24 1988-07-26 David Rubin Combined fatty acid composition for lowering blood cholestrol and triglyceride levels
HU202088B (en) * 1987-03-18 1991-02-28 Caola Kozmetikai Method for producing dietetic preparation
HU204199B (en) * 1987-03-18 1991-12-30 Caola Kozmetikai Process for producing pharmaceutical compositions containing unsaturated fatty acids and selenium as active components
HU209973B (en) * 1988-03-09 1995-01-30 Biorex Kutato Fejlesztoe Kft Process for production of antiviral and immunstimular pharmaceutical composition

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR19990015198A (ko) * 1997-08-02 1999-03-05 손남율 식물성 항생제

Also Published As

Publication number Publication date
FR2628972B1 (fr) 1994-09-23
DE3909707A1 (de) 1989-10-05
IT1229205B (it) 1991-07-25
GB8906856D0 (en) 1989-05-10
SE8901041L (sv) 1989-09-24
SE8901041D0 (sv) 1989-03-23
LU87488A1 (fr) 1990-10-02
NL8900742A (nl) 1989-10-16
IT8919876A0 (it) 1989-03-23
BE1003021A3 (fr) 1991-10-29
HU210122B (en) 1995-02-28
FR2628972A1 (fr) 1989-09-29
GB2216421A (en) 1989-10-11
ES2014060A6 (es) 1990-06-16
HUT60436A (en) 1992-09-28
FI891438A0 (fi) 1989-03-23
CH677732A5 (ko) 1991-06-28
CA1319607C (en) 1993-06-29
FI891438A (fi) 1989-09-24
JPH0222228A (ja) 1990-01-25

Similar Documents

Publication Publication Date Title
KR890014104A (ko) 심장과 심맥관계에 특히 작용하는 약학적 조성과 이의 제조방법 공정
KR840008264A (ko) 살서제 조성물
CA2207218A1 (en) Controlled release composition forming a reversed micellar (l2) structure or a normal micellar (l1) structure
KR890000085A (ko) 필수지방산 합성물(Essential Fatty Acid Compositions)
KR880007069A (ko) 트리글리세라이드 조성물
KR870006894A (ko) 니코란딜의 안정화제제의 제조방법
KR910000157A (ko) 흡수성이 개선된 비타민 e 조성물
JPS5785366A (en) 2-mercaptoquinone derivative
ES461613A1 (es) Un metodo de preparacion de una composicion de colageno.
KR900011470A (ko) 외용제
ES2009569A6 (es) Procedimiento de preparacion de una composicion farmaceutica a base de algas que contengan selenio que actua sobre el corazon y el sistema cardiovascular.
KR840007808A (ko) 트리시클로 헥실-틴 벤조에이트로 이루어진 주석유기 유도체의 제조방법
ATE98479T1 (de) Arznei-lipid-zusammensetzung fuer parenterale nahrung.
KR900005955A (ko) 페이스트상 치아 연마 조성물
Henderson et al. Polyunsaturated fatty acid composition of the salmon (Salmo salar L.) pineal organ: modification by diet and effect on prostaglandin production
KR900018123A (ko) 광학적 활성인 d-2-n-펜아세틸아미노-4-메틸 포스피노부티르산의 라세미화 방법
KR830010091A (ko) 구연산 나프티드로푸릴의 제조방법
JPS5664772A (en) Storage of food
KR830003885A (ko) 요오드 고함유란(高含有卵)을 주성분으로 하는 지질대사 개선용 조성물의 제조방법
JPS5786254A (en) Healthful food
KR910012222A (ko) 화장비누 조성물
KR920002678A (ko) 생분해성 폴리에틸렌- 전분 베이스 필름의 제조방법
JPS53103412A (en) Preparation of farnesyl acetic acid or its ester
JPS57130912A (en) High-calorie tranfusion preparation
KR890007650A (ko) 산초 추출물을 첨가한 김치류의 보존 연장 방법

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid